Cargando…
Computational Study of Gleevec and G6G Reveals Molecular Determinants of Kinase Inhibitor Selectivity
[Image: see text] Gleevec is a potent inhibitor of Abl tyrosine kinase but not of the highly homologous c-Src kinase. Because the ligand binds to an inactive form of the protein in which an Asp-Phe-Gly structural motif along the activation loop adopts a so-called DFG-out conformation, it was suggest...
Autores principales: | Lin, Yen-Lin, Meng, Yilin, Huang, Lei, Roux, Benoît |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210138/ https://www.ncbi.nlm.nih.gov/pubmed/25243930 http://dx.doi.org/10.1021/ja504146x |
Ejemplares similares
-
Energetic dissection of Gleevec’s selectivity towards human tyrosine kinases
por: Agafonov, R.V., et al.
Publicado: (2014) -
Computational
Study of the “DFG-Flip”
Conformational Transition
in c-Abl and c-Src Tyrosine Kinases
por: Meng, Yilin, et al.
Publicado: (2014) -
Gleevec, an Abl Family Inhibitor, Produces a Profound Change in Cell Shape and Migration
por: Chen, Zaozao, et al.
Publicado: (2013) -
Effects of STI571 (gleevec) on pancreatic cancer cell growth
por: Li, Junsheng, et al.
Publicado: (2003) -
Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec(®), Gleevec™)
por: Henkes, Martin, et al.
Publicado: (2008)